Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Erypharm Logo
Erypharm Growth Score
31
CB Rank
132379
Heat Score
65
EryPharm is a biotech company for the industrial culture of red blood cells from stem cells.
Founded
obfuscation
PrivateSeed Paris, Ile-de-France, France11-50 erypharm.com/
Biotechnology
Overview

Erypharm
Total Funding
obfuscation
Growth Score
31
Heat Score
65

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score31
-1 pts
in past quarter
Heat Score 65
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Erypharm

CB Rank
132379
EryPharm is a biotech company for the industrial culture of red blood cells from stem cells.
Founded
obfuscation
PrivateSeed Paris, Ile-de-France, France11-50 erypharm.com/
Biotechnology

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Erypharm SAS
Operating Status Active
Company Type For Profit
Founders  Luc Douay
About the Company
EryPharm is a biotech business that produces red blood cells for industrial use from stem cells. They produce cultured red blood cells, creating blood transfusion products. Their product notably is for the treatment of blood disorders and cancer patients, who require multiple transfusions.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Cultured Red Blood Cells (cRBC)
Red blood cells produced industrially from human hematopoietic stem cells for transfusion purposes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed
obfuscation
Seed Round - Erypharm Logo
Seed Round - Erypharm
2
obfuscation
CorelySeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Corely Logo
Corely
Yes
Seed Round - Erypharm Logo
Seed Round - Erypharm
—
Corely Logo
Corely
Yes
Seed Round - Erypharm Logo
Seed Round - Erypharm
—
Corely Logo
Corely
Yes
Seed Round - Erypharm Logo
Seed Round - Erypharm
—
Corely Logo
Corely
Yes
Seed Round - Erypharm Logo
Seed Round - Erypharm
—
Corely Logo
Corely
Yes
Seed Round - Erypharm Logo
Seed Round - Erypharm
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$263.6KThis year, Erypharm is projected to spend $263.6K on IT, according to Aberdeen.

Active Website Tech Count

12Erypharm is actively using 12 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, HSTS, and  nginx.

Total IP

4The intellectual property of Erypharm includes 4 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Erypharm's headquarters? Erypharm is located in Paris, Ile-de-France, France.Who invested in Erypharm? Erypharm has 2 investors including Corely and  AGORANOV.When was the last funding round for Erypharm? Erypharm closed its last funding round on
obfuscation
from a Seed round.Who are Erypharm's competitors? Alternatives and possible competitors to Erypharm may include Grifols, BlueRock Therapeutics, and  Terumo BCT.How much funding has Erypharm raised to date? Erypharm has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|